explore
Previous article:
Psychedelics group wrestles with new pharma identity
Next article: FDA advisers vote against ALS treatment from BrainStorm
Next article: FDA advisers vote against ALS treatment from BrainStorm
knowledge
focus
-
Data show record exodus of life scientists from academia
2025-09-14 14:43 -
Medicare drug price negotiation program allowed for now
2025-09-14 14:29 -
Mindstrong's demise and the future of mental health care
2025-09-14 13:23 -
A new study asks: Are we harming blood donors by taking blood?
2025-09-14 13:12 -
Grail is spending more than ever lobbying Congress
2025-09-14 13:08 -
Ionis has late
2025-09-14 12:06